Body size and longitudinal body weight changes do not increase mortality in incident peritoneal dialysis patients of the Brazilian peritoneal dialysis multicenter study

Clinics

Volumn 68, Issue 1, 2013, Pages 51-58

  Fernandes, Natália Maria da Silva ^a   Bastos, Marcus Gomes ^a   Franco, Márcia Regina Gianotti ^a,b   Chaoubah, Alfredo ^a   Lima, Maria da Glória ^b   Divino Filho, José Carolino ^c   Qureshi, Abdul Rashid ^c  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b GAMEN   (Brazil)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cohort study; Incident; Obesity; Overweight; Peritoneal dialysis; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; BODY SIZE; BRAZIL; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; OBESITY; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PHYSIOLOGY; RISK FACTOR; SEX RATIO; TREATMENT OUTCOME;

ADULT; AGED; BODY MASS INDEX; BODY SIZE; BRAZIL; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PERITONEAL DIALYSIS; RISK FACTORS; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 84874119734     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2013(01)OA08     Document Type: Article

References (40)

1. Sichieri R, do Nascimento S, Coutinho W. The burden of hospitalization due to overweight and obesity in Brazil. Cad Saude Publica. 2007;23(7):1721-7, http://dx.doi.org/10.1590/S0102-311X2007000700025.
2. Abbott KC, Oliver DK, Hurst FP, Das NP, Gao SW, Perkins RM. Body mass index and peritoneal dialysis: "exceptions to the exception" in reverse epidemiology? Semin Dial. 2007;20(6):561-5, http://dx.doi.org/10.1111/j.1525-139X.2007.00347.x.
3. Chazot C, Gassia JP, Di Benedetto A, Cesare S, Ponce P, Marcelli D. Is there any survival advantage of obesity in Southern European haemodialysis patients? Nephrol Dial Transplant. 2009;24(9):2871-6, http://dx.doi.org/10.1093/ndt/gfp168.
4. Beddhu S. The body mass index paradox and an obesity, inflammation, and atherosclerosis syndrome in chronic kidney disease. Semin Dial. 2004;17(3):229-32, http://dx.doi.org/10.1111/j.0894-0959.2004.17311.x.
5. Kalantar-Zadeh K. Causes and consequences of the reverse epidemiology of body mass index in dialysis patients. J Ren Nutr. 2005;15(1):142-7.
6. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81(3):543-54.
7. Kalantar-Zadeh K, Kopple JD. Obesity paradox in patients on maintenance dialysis. Contrib Nephrol. 2006;151:57-69, http://dx.doi.org/10. 1159/000095319.
8. Pliakogiannis T, Trpeski L, Taskapan H, Shah H, Ahmad M, Fenton S, et al. Reverse epidemiology in peritoneal dialysis patients: the Canadian experience and review of the literature. Int Urol Nephrol. 2007;39(1):281-8, http://dx.doi.org/10.1007/s11255-006-9142-1.
9. Johnson DW. What is the optimal fat mass in peritoneal dialysis patients? Perit Dial Int. 2007;27 Suppl 2:S250-4.
10. de Araujo Antunes A, Vannini FD, Martin LC, Balbi AL, Ponce D, Nunes HR, et al. Inflammation and overweight in peritoneal dialysis: is there an association? Renal Fail. 2009;31(7):549-54, http://dx.doi.org/10.1080/08860220903050397.
11. McDonald SP, Collins JF, Johnson DW. Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol. 2003;14(11):2894-901, http://dx.doi.org/10.1097/01.ASN.0000091587.55159.5F.
12. McDonald SP, Collins JF, Rumpsfeld M, Johnson DW. Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations. Perit Dial Int. 2004;24(4):340-6.
13. Bernardo AP, Fonseca I, Rodrigues A, Carvalho MJ, Cabrita A. Overweight rather than malnutrition is widely prevalent in peritoneal dialysis patients. Adv Perit Dial. 2009;25:119-24.
14. Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ. Body size and outcomes on peritoneal dialysis in the United States. Kidney Int. 2003;64(5):1838-44, http://dx.doi.org/10.1046/j.1523-1755.2003.00287.x.
15. Ramkumar N, Pappas LM, Beddhu S. Effect of body size and body composition on survival in peritoneal dialysis patients. Perit Dial Int. 2005;25(5):461-9.
16. Pellicano R, Strauss BJ, Polkinghome KR, Kerr PG. Longitudinal Body Composition Changes Due to Dialysis. Clin J Am Soc Nephro. 2011;6(7):1668-75, http://dx.doi.org/10.2215/CJN.06790810.
17. Fernandes N, Bastos MG, Cassi HV, Machado NL, Ribeiro JA, Martins G, et al. The Brazilian Peritoneal Dialysis Multicenter Study (BRAZPD): characterization of the cohort. Kidney Int Suppl. 2008(108):S145-51, http://dx.doi.org/10.1038/sj.ki.5002616.
18. IBGE. Brazilian Institute of Geography and Statistical-IBGE. Brazil: Brazilian Institute of Geography and Statistical-IBGE; 2007 [cited 2008 april 2008].
19. Davies SJ, Phillips L, Naish PF, Russell GI. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant. 2002;17(6):1085-92, http://dx.doi. org/10.1093/ndt/17.6.1085.
20. Vongpatanasin W. Cardiovascular morbidity and mortality in high-risk populations: epidemiology and opportunities for risk reduction. J Clin Hypertens (Greenwich). 2007;9(11 Suppl 4):11-5, http://dx.doi.org/10. 1111/j.1524-6175.2007.07722.x.
21. Qatanani M, Lazar MA. Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 2007;21(12):1443-55, http://dx.doi.org/10.1101/gad.1550907.
22. Hagymasi K, Tulassay Z. [Role of obesity in colorectal carcinogenesis.]. Orv Hetil. 2007;148(51):2411-6. Az elhizas szerepe a vastagbeldaganatok kialakulasaban, http://dx.doi.org/10.1556/OH.2007.28244.
23. Axelsson J. Obesity in chronic kidney disease: good or bad? Blood Purif. 2008;26(1):23-9, http://dx.doi.org/10.1159/000110559.
24. Kramer H, Luke A. Obesity and kidney disease: a big dilemma. Curr Opin Nephrol Hypertens. 2007;16(3):237-41, http://dx.doi.org/10.1097/MNH.0b013e32803578e4.
25. Dekker FW, de Mutsert R, van Dijk PC, Zoccali C, Jager KJ. Survival analysis: time-dependent effects and time-varying risk factors. Kidney Int. 2008;74(8):994-7, http://dx.doi.org/10.1038/ki.2008.328.
26. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S112-9.
27. de Mutsert R, Snijder MB, van der Sman-de Beer F, Seidell JC, Boeschoten EW, Krediet RT, et al. Association between body mass index and mortality is similar in the hemodialysis population and the general population at high age and equal duration of follow-up. J Am Soc Nephrol. 2007;18(3):967-74, http://dx.doi.org/10.1681/ASN.2006091050.
28. Horwich TB, Fonarow GC. Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD and AIDS. Semin Dial. 2007;20(6):549-53, http://dx.doi.org/10.1111/j. 1525-139X.2007.00346.x.
29. Horwich TB, Fonarow GC. The impact of obesity on survival in patients with heart failure. Heart Fail Monit. 2002;3(1):8-14.
30. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341(8):577-85.
31. Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimburger O, Zhang Z, Hoff C, et al. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int. 2004;65(1):274-81, http://dx.doi.org/10.1111/j.1523-1755.2004.00370.x.
32. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, Wu DY. Reverse epidemiology: a spurious hypothesis or a hardcore reality? Blood Purif. 2005;23(1):57-63, http://dx.doi.org/10.1159/000082012.
33. Duran M, Unal A, Inanc MT, Esin F, Yilmaz Y, Ornek E. Effect of maintenance hemodialysis on diastolic left ventricular function in endstage renal disease. Clinics. 2010;65(10):979-84, http://dx.doi.org/10. 1590/S1807-59322010001000010.
34. Agarwal R. Body mass index-mortality paradox in hemodialysis: can it be explained by blood pressure? Hypertension. 2011;58(6):1014-20, http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.180091.
35. Weir MR. Body mass index-mortality paradox in hemodialysis patients: blood pressure, blood volume, and nutritional status. Hypertension. 2011;58(6):989-90, http://dx.doi.org/10.1161/HYPERTENSIONAHA.111. 181818.
36. de Mutsert R, Grootendorst DC, Boeschoten EW, Dekker FW, Krediet RT. Is obesity associated with a survival advantage in patients starting peritoneal dialysis? Contrib Nephrol. 2009;163:124-31, http://dx.doi. org/10.1159/000223790.
37. Hoogeveen EK, Halbesma N, Rothman KJ, Stijnen T, van Dijk S, Dekker FW, et al. Obesity and Mortality Risk among Younger Dialysis Patients. Clin J Am Soc Nephrol. 2012;7(2):280-8, http://dx.doi.org/10.2215/CJN. 05700611.
38. de Andrade Bastos K, Qureshi AR, Lopes AA, Fernandes N, Barbosa LM, Pecoits-Filho R, et al. Family income and survival in Brazilian Peritoneal Dialysis Multicenter Study Patients (BRAZPD): time to revisit a myth? Clin J Am Soc Nephrol. 2011;6(7):1676-83, http://dx.doi.org/10.2215/CJN.09041010.
39. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1996;7(2):198-207.
40. Brown E, Davies S, Rutherford P, Meeus F, Borras M, Riegel W, et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol. 2003;14(11):2948-57, http://dx.doi.org/10.1097/01.ASN.0000092146.67909.e2",-1, "xxx/67909.e2.